The diagnostic value of rapid urine test platform UF-5000 for suspected urinary tract infection at the emergency department

Link to article at PubMed

Front Cell Infect Microbiol. 2022 Sep 27;12:936854. doi: 10.3389/fcimb.2022.936854. eCollection 2022.


BACKGROUND AND OBJECTIVE: Urine culture is time consuming, which may take days to get the results and impede further timely treatment. Our objective is to evaluate whether the fast urinalysis and bacterial discrimination system called Sysmex UF-5000 may predict urinary tract infections (UTIs) (within minutes) compared with the clinical routine test in suspected UTI patients. In addition, we aimed to explore the accuracy of microbiologic information by UF-5000.

MATERIALS AND METHODS: Consecutive patients who were admitted from the emergency department at Queen Mary Hospital (a tertiary hospital in Hong Kong) from June 2019 to February 2020 were enrolled in the present study. The dipstick test, manual microscopic test with culture, and Sysmex UF-5000 test were performed in the urine samples at admission.

RESULTS: A total of 383 patients were finally included in the present study. UF-5000 urinalysis (area under the receiver operator characteristic curve, AUC=0.821, confidence interval, 95%CI: 0.767-0.874) outperformed the dipstick test (AUC=0.602, 95%CI: 0.550-0.654, P=1.32×10-10) for predicting UTIs in patients without prior antibiotic treatment. A significant net benefit from UF-5000 was observed compared with the dipstick test (NRI=39.9%, 95%CI: 19.4-60.4, P=1.36 × 10-4). The urine leukocyte tested by UF-5000 had similar performance (AUC) for predicting UTI compared with the manual microscopic test (P=0.27). In patients without a prior use of antibiotics, the concordance rates between UF-5000 and culture for predicting Gram-positive or -negative bacteriuria and a negative culture were 44.7% and 96.2%, respectively.

CONCLUSIONS: UF-5000 urinalysis had a significantly better predictive value than the dipstick urine test for predicting UTIs.

PMID:36237433 | PMC:PMC9551190 | DOI:10.3389/fcimb.2022.936854

Leave a Reply

Your email address will not be published. Required fields are marked *